Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Different dosages of intravitreal triamcinolone acetonide injections for macular edema secondary to central retinal vein occlusion.

Wei Y, Wang H, Chen F, Zu Z, Bi C, Yang X.

Eye Sci. 2012 Sep;27(3):152-7.

PMID:
22993062
[PubMed - in process]
2.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
[PubMed - indexed for MEDLINE]
3.

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.

Kim JY, Park SP.

Korean J Ophthalmol. 2009 Dec;23(4):259-65. doi: 10.3341/kjo.2009.23.4.259. Epub 2009 Dec 4.

PMID:
20046685
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.

Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA.

Arch Ophthalmol. 2004 Aug;122(8):1131-6.

PMID:
15302652
[PubMed - indexed for MEDLINE]
5.

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.

Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.

Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.

PMID:
18327140
[PubMed - indexed for MEDLINE]
6.

Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.

Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ohji M.

Acta Ophthalmol. 2013 Jun;91(4):318-24. doi: 10.1111/j.1755-3768.2011.02298.x. Epub 2011 Dec 1.

PMID:
22132711
[PubMed - indexed for MEDLINE]
7.

Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.

Yamashita T, Uemura A, Kita H, Sakamoto T.

J Glaucoma. 2007 Mar;16(2):220-4.

PMID:
17473734
[PubMed - indexed for MEDLINE]
8.

Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.

Hayashi K, Hayashi H.

Am J Ophthalmol. 2005 Jun;139(6):972-82.

PMID:
15953425
[PubMed - indexed for MEDLINE]
9.

Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.

Hou J, Tao Y, Jiang YR, Li XX, Gao L.

Chin Med J (Engl). 2009 Nov 20;122(22):2695-9.

PMID:
19951598
[PubMed - indexed for MEDLINE]
Free Article
10.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

CekiƧ O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
[PubMed - indexed for MEDLINE]
11.

Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.

Lin JM, Chiu YT, Hung PT, Tsai YY.

Retina. 2007 Feb;27(2):180-9.

PMID:
17290200
[PubMed - indexed for MEDLINE]
12.

[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].

Selim Kocabora M, Kucuksahin H, Gulkilik G, Taskapili M, Yilmazli C, Engin G.

J Fr Ophtalmol. 2007 Jan;30(1):32-8. French.

PMID:
17287669
[PubMed - indexed for MEDLINE]
Free Article
13.

Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.

Patel PJ, Zaheer I, Karia N.

Eye (Lond). 2008 Jan;22(1):60-4. Epub 2006 Aug 11.

PMID:
16902493
[PubMed - indexed for MEDLINE]
14.

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.

Wu WC, Cheng KC, Wu HJ.

Eye (Lond). 2009 Dec;23(12):2215-22. doi: 10.1038/eye.2008.429. Epub .

PMID:
19218991
[PubMed - indexed for MEDLINE]
15.

Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion.

Wang HY, Li X, Wang YS, Zhang ZF, Li MH, Su XN, Zhu JT.

Int J Ophthalmol. 2011;4(1):89-94. doi: 10.3980/j.issn.2222-3959.2011.01.21. Epub 2011 Feb 18.

PMID:
22553618
[PubMed]
Free PMC Article
16.

[Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].

Le Moigne O, Duncombe A, Portmann A, Muraine M, Genevois O.

J Fr Ophtalmol. 2012 Nov;35(9):700-4. doi: 10.1016/j.jfo.2011.11.015. Epub 2012 Aug 24. French.

PMID:
22925843
[PubMed - indexed for MEDLINE]
Free Article
17.

Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.

Avitabile T, Longo A, Reibaldi A.

Am J Ophthalmol. 2005 Oct;140(4):695-702.

PMID:
16226521
[PubMed - indexed for MEDLINE]
18.

[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].

Saleh M, Gaucher D, Letsch J, Bourcier T, Speeg-Schatz C.

J Fr Ophtalmol. 2011 Jun;34(6):355-61. doi: 10.1016/j.jfo.2011.04.008. Epub 2011 Jun 8. French.

PMID:
21652108
[PubMed - indexed for MEDLINE]
Free Article
19.

Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.

Gurram MM.

J Clin Diagn Res. 2013 Dec;7(12):2821-4. doi: 10.7860/JCDR/2013/6473.3766. Epub 2013 Sep 13.

PMID:
24551647
[PubMed]
Free PMC Article
20.

Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.

Hirano Y, Ito T, Nozaki M, Yasukawa T, Sakurai E, Yoshida M, Ogura Y.

Jpn J Ophthalmol. 2009 Sep;53(5):519-22. doi: 10.1007/s10384-009-0692-5. Epub 2009 Oct 22.

PMID:
19847609
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk